Dr. Adam Yuh Lin, MD, PhD

Dr. Lin practices at Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare.

Dr. Lin's NPI, 1467846360, was assigned on March 28, 2015. Dr. Lin graduated from Baylor College of Medicine in 2014. Dr. Lin holds Illinois license 036144590.

Dr. Lin's primary practice is Northwestern Memorial Hospital, at 251 E Huron St, Chicago, IL 60611 in Cook County. The practice phone is (312) 926-2000.

Dr. Lin's primary practice is Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Lin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lin is licensed in Illinois.

CMS data shows 359 Medicare services from Dr. Lin across 3 procedure codes in 2024, for 80 Medicare patients. Medicare paid $26,500 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 18% are also on Medicaid. Their average risk score is 3.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 67, with 55% women.

In 2016, Dr. Lin wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $132 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Lin for performance year 2024, reported through an alternative payment model (APM). Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 29 papers to Dr. Lin, published from 2011 to 2025. 2013 was the busiest year, with 5. The most frequent topics are Gold, Metal Nanoparticles and Immunotherapy, Adoptive. Dr. Lin has published most often in Nanoscale Res Lett. Dr. Lin's most frequent co-authors are Leo I. Gordon, MD, Leo Gordon, MD and Reem Md Karmali, MD.

CMS Open Payments shows 17 general payments to Dr. Lin from 9 drug and device companies from 2019 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. Abbvie Inc. paid the most, $3,933.

Dr. Lin graduated from Baylor College of Medicine in 2014.